JP2013500012A5 - - Google Patents

Download PDF

Info

Publication number
JP2013500012A5
JP2013500012A5 JP2012521750A JP2012521750A JP2013500012A5 JP 2013500012 A5 JP2013500012 A5 JP 2013500012A5 JP 2012521750 A JP2012521750 A JP 2012521750A JP 2012521750 A JP2012521750 A JP 2012521750A JP 2013500012 A5 JP2013500012 A5 JP 2013500012A5
Authority
JP
Japan
Prior art keywords
cell
endothelial cells
cells
reduce
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012521750A
Other languages
English (en)
Japanese (ja)
Other versions
JP6243119B2 (ja
JP2013500012A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/042726 external-priority patent/WO2011011500A1/en
Publication of JP2013500012A publication Critical patent/JP2013500012A/ja
Publication of JP2013500012A5 publication Critical patent/JP2013500012A5/ja
Application granted granted Critical
Publication of JP6243119B2 publication Critical patent/JP6243119B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012521750A 2009-07-21 2010-07-21 白血球溢出を低下させる幹細胞の使用 Active JP6243119B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22730909P 2009-07-21 2009-07-21
US61/227,309 2009-07-21
PCT/US2010/042726 WO2011011500A1 (en) 2009-07-21 2010-07-21 Use of stem cells to reduce leukocyte extravasation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014222204A Division JP6325419B2 (ja) 2009-07-21 2014-10-31 白血球溢出を低下させる幹細胞の使用

Publications (3)

Publication Number Publication Date
JP2013500012A JP2013500012A (ja) 2013-01-07
JP2013500012A5 true JP2013500012A5 (OSRAM) 2013-04-25
JP6243119B2 JP6243119B2 (ja) 2017-12-06

Family

ID=43497499

Family Applications (7)

Application Number Title Priority Date Filing Date
JP2012521750A Active JP6243119B2 (ja) 2009-07-21 2010-07-21 白血球溢出を低下させる幹細胞の使用
JP2014222204A Active JP6325419B2 (ja) 2009-07-21 2014-10-31 白血球溢出を低下させる幹細胞の使用
JP2016082666A Pending JP2016129523A (ja) 2009-07-21 2016-04-18 白血球溢出を低下させる幹細胞の使用
JP2018025725A Withdrawn JP2018086011A (ja) 2009-07-21 2018-02-16 白血球溢出を低下させる幹細胞の使用
JP2019199927A Withdrawn JP2020028298A (ja) 2009-07-21 2019-11-01 白血球溢出を低下させる幹細胞の使用
JP2021139876A Withdrawn JP2021182941A (ja) 2009-07-21 2021-08-30 白血球溢出を低下させる幹細胞の使用
JP2023087113A Pending JP2023099831A (ja) 2009-07-21 2023-05-26 白血球溢出を低下させる幹細胞の使用

Family Applications After (6)

Application Number Title Priority Date Filing Date
JP2014222204A Active JP6325419B2 (ja) 2009-07-21 2014-10-31 白血球溢出を低下させる幹細胞の使用
JP2016082666A Pending JP2016129523A (ja) 2009-07-21 2016-04-18 白血球溢出を低下させる幹細胞の使用
JP2018025725A Withdrawn JP2018086011A (ja) 2009-07-21 2018-02-16 白血球溢出を低下させる幹細胞の使用
JP2019199927A Withdrawn JP2020028298A (ja) 2009-07-21 2019-11-01 白血球溢出を低下させる幹細胞の使用
JP2021139876A Withdrawn JP2021182941A (ja) 2009-07-21 2021-08-30 白血球溢出を低下させる幹細胞の使用
JP2023087113A Pending JP2023099831A (ja) 2009-07-21 2023-05-26 白血球溢出を低下させる幹細胞の使用

Country Status (12)

Country Link
US (2) US20110020293A1 (OSRAM)
EP (2) EP3831930A1 (OSRAM)
JP (7) JP6243119B2 (OSRAM)
KR (2) KR20180014224A (OSRAM)
CN (2) CN104962512B (OSRAM)
AU (1) AU2010276201B2 (OSRAM)
BR (1) BR112012001329B1 (OSRAM)
CA (1) CA2768576C (OSRAM)
DK (1) DK2456853T3 (OSRAM)
IL (1) IL217648B (OSRAM)
SG (3) SG178064A1 (OSRAM)
WO (1) WO2011011500A1 (OSRAM)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101978047A (zh) 2008-01-18 2011-02-16 明尼苏达大学董事会 干细胞聚集体及制备和使用方法
CA2781194A1 (en) * 2009-11-19 2011-05-26 Regents Of The University Of Minnesota Reducing inflammation using cell therapy
WO2011106476A1 (en) * 2010-02-25 2011-09-01 Abt Holding Company Modulation of microglia activation
ES2703428T3 (es) * 2010-02-25 2019-03-08 Abt Holding Co Modulación de la angiogénesis
SG185526A1 (en) 2010-05-12 2012-12-28 Abt Holding Co Modulation of splenocytes in cell therapy
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
SG10201914092XA (en) * 2011-06-06 2020-03-30 ReGenesys BVBA Expansion of stem cells in hollow fiber bioreactors
US9901625B2 (en) 2011-10-15 2018-02-27 University Of Maryland, College Park Methods of regulating uptake and transcellular transport of leukocytes and therapeutics
WO2013123084A1 (en) * 2012-02-13 2013-08-22 Minerva Biotechnologies Corporation Method for detecting circulating fetal cells
CA2909267C (en) 2013-04-12 2022-10-25 Saverio LA FRANCESCA Improving organs for transplantation
WO2016187413A1 (en) 2015-05-21 2016-11-24 Musculoskeletal Transplant Foundation Modified demineralized cortical bone fibers
US10894255B2 (en) * 2015-07-02 2021-01-19 Nanyang Technological University Leukocyte and microparticles fractionation using microfluidics
WO2017127123A1 (en) 2016-01-21 2017-07-27 Abt Holding Company Stem cells for wound healing
KR20200003160A (ko) * 2017-05-03 2020-01-08 바이오마린 파머수티컬 인크. 조혈모세포의 형질도입을 위한 개선된 렌티바이러스
WO2021194272A1 (ko) * 2020-03-25 2021-09-30 울산과학기술원 질환 상태의 백혈구를 검출하거나, 백혈구 관련 질환을 진단하는 장치 또는 방법
CN115605754A (zh) * 2020-04-20 2023-01-13 美商生命科学有限公司(Us) 效价测定

Family Cites Families (110)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US5192553A (en) 1987-11-12 1993-03-09 Biocyte Corporation Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use
EP0435928A1 (en) 1988-09-21 1991-07-10 Animal Biotechnology Cambridge Limited Derivation of pluripotential embryonic cell lines from domestic animals
US7037721B1 (en) 1990-01-29 2006-05-02 Hy-Gene Biomedical, Inc. Protein-free defined media for the growth of normal human keratinocytes
US5061620A (en) 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US5635387A (en) 1990-04-23 1997-06-03 Cellpro, Inc. Methods and device for culturing human hematopoietic cells and their precursors
US5811094A (en) 1990-11-16 1998-09-22 Osiris Therapeutics, Inc. Connective tissue regeneration using human mesenchymal stem cell preparations
US5486359A (en) * 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5837539A (en) 1990-11-16 1998-11-17 Osiris Therapeutics, Inc. Monoclonal antibodies for human mesenchymal stem cells
GB2254289B (en) 1991-04-05 1995-03-22 Gerber Garment Technology Inc Readily transferrable adherent tape and methods of use and making
US5851832A (en) 1991-07-08 1998-12-22 Neurospheres, Ltd. In vitro growth and proliferation of multipotent neural stem cells and their progeny
AU2882992A (en) 1991-11-06 1993-06-07 Arthur A. Axelrad Cell culture medium
US5460964A (en) 1992-04-03 1995-10-24 Regents Of The University Of Minnesota Method for culturing hematopoietic cells
US5340740A (en) 1992-05-15 1994-08-23 North Carolina State University Method of producing an avian embryonic stem cell culture and the avian embryonic stem cell culture produced by the process
AU4543193A (en) * 1992-06-22 1994-01-24 Henry E. Young Scar inhibitory factor and use thereof
US5849553A (en) 1992-07-27 1998-12-15 California Institute Of Technology Mammalian multipotent neural stem cells
US5564183A (en) 1992-09-30 1996-10-15 Matsushita Electric Industrial Co., Ltd. Producing system of printed circuit board and method therefor
US7153684B1 (en) 1992-10-08 2006-12-26 Vanderbilt University Pluripotential embryonic stem cells and methods of making same
US5453357A (en) 1992-10-08 1995-09-26 Vanderbilt University Pluripotential embryonic stem cells and methods of making same
US5766951A (en) 1992-11-12 1998-06-16 Quality Biological, Inc. Serum-free medium supporting growth and proliferation of normal bone marrow cells
US5766948A (en) 1993-01-06 1998-06-16 The Regents Of The University Of California Method for production of neuroblasts
US6037174A (en) 1993-08-23 2000-03-14 Nexell Therapeutics, Inc. Preparation of serum-free suspensions of human hematopoietic cells or precursor cells
US5409813A (en) 1993-09-30 1995-04-25 Systemix, Inc. Method for mammalian cell separation from a mixture of cell populations
US6432711B1 (en) 1993-11-03 2002-08-13 Diacrin, Inc. Embryonic stem cells capable of differentiating into desired cell lines
FR2726003B1 (fr) 1994-10-21 2002-10-18 Agronomique Inst Nat Rech Milieu de culture de cellules embryonnaires totipotentes aviaires, procede de culture de ces cellules, et cellules embryonnaires totipotentes aviaires
US5677136A (en) 1994-11-14 1997-10-14 Systemix, Inc. Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof
US5914268A (en) 1994-11-21 1999-06-22 National Jewish Center For Immunology & Respiratory Medicine Embryonic cell populations and methods to isolate such populations
US5874301A (en) 1994-11-21 1999-02-23 National Jewish Center For Immunology And Respiratory Medicine Embryonic cell populations and methods to isolate such populations
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
US5736396A (en) 1995-01-24 1998-04-07 Case Western Reserve University Lineage-directed induction of human mesenchymal stem cell differentiation
GB9502022D0 (en) * 1995-02-02 1995-03-22 Abuljadayel Ilham M S A method for preparing lymphohaematopoietic progenitor cells
US5906934A (en) * 1995-03-14 1999-05-25 Morphogen Pharmaceuticals, Inc. Mesenchymal stem cells for cartilage repair
US6653134B2 (en) * 1995-03-28 2003-11-25 Cp Hahnemann University Isolated stromal cells for use in the treatment of diseases of the central nervous system
US5837670A (en) 1995-04-18 1998-11-17 Hartshorn; Richard Timothy Detergent compositions having suds suppressing properties
US5908782A (en) 1995-06-05 1999-06-01 Osiris Therapeutics, Inc. Chemically defined medium for human mesenchymal stem cells
US6015554A (en) 1995-06-07 2000-01-18 Systemix, Inc. Method of reconstituting human lymphoid and dendritic cells
DE69738368T2 (de) * 1996-03-08 2008-12-04 The Regents Of The University Of Michigan, Ann Arbor MURINE alpha(1,3)-FUCOSYLTRANSFERASE (Fuc-TVII)
US6190910B1 (en) 1996-05-21 2001-02-20 The Institute Of Physical And Chemical Research Mouse embryonic stem cell lines
US5753506A (en) 1996-05-23 1998-05-19 Cns Stem Cell Technology, Inc. Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals
US5827740A (en) 1996-07-30 1998-10-27 Osiris Therapeutics, Inc. Adipogenic differentiation of human mesenchymal stem cells
US5945337A (en) 1996-10-18 1999-08-31 Quality Biological, Inc. Method for culturing CD34+ cells in a serum-free medium
US6361996B1 (en) 1997-05-07 2002-03-26 University Of Utah Research Foundation Neuroepithelial stem cells and glial-restricted intermediate precursors
WO1998059035A2 (en) 1997-06-25 1998-12-30 The Goverment Of The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services, National Institutes Of Health Serum-free cell growth medium
AU755657B2 (en) 1997-07-04 2002-12-19 University Of Utah Research Foundation Lineage-restricted neuronal precursors
CA2296704C (en) * 1997-07-14 2010-10-19 Osiris Therapeutics, Inc. Cardiac muscle regeneration using mesenchymal stem cells
US5968829A (en) 1997-09-05 1999-10-19 Cytotherapeutics, Inc. Human CNS neural stem cells
WO1999047163A2 (en) * 1998-03-18 1999-09-23 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
US6368636B1 (en) * 1998-03-18 2002-04-09 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
PT1066060E (pt) * 1998-04-03 2003-12-31 Osiris Therapeutics Inc Celulas estaminais mesenquimais como imunossupressores
US6541247B1 (en) * 1998-06-25 2003-04-01 Neuronova Ab Method of isolating ependymal neural stem cells
SE9802264D0 (sv) * 1998-06-25 1998-06-25 Neuronova Ab A method of isolating cells
WO2000027995A1 (en) 1998-11-09 2000-05-18 Monash University Embryonic stem cells
RU2272839C2 (ru) 1998-11-09 2006-03-27 Консорцио Пер Ла Джестионе Дель Чентро Ди Биотекнолоджие Аванцате Бессывороточная среда для культуры клеток, используемых для реконструкции костных и хрящевых сегментов (варианты)
EP1137421A1 (en) * 1998-11-13 2001-10-04 Osiris Therapeutics, Inc. Uses of fibroblasts or supernatants from fibroblasts for the suppression of immune responses in transplantation
US6777231B1 (en) * 1999-03-10 2004-08-17 The Regents Of The University Of California Adipose-derived stem cells and lattices
US20050153442A1 (en) 1999-03-10 2005-07-14 Adam Katz Adipose-derived stem cells and lattices
US20050169896A1 (en) * 1999-05-14 2005-08-04 Henry Ford Health System Bone marrow transplantation for treatment of stroke
US7015037B1 (en) * 1999-08-05 2006-03-21 Regents Of The University Of Minnesota Multiponent adult stem cells and methods for isolation
US8075881B2 (en) * 1999-08-05 2011-12-13 Regents Of The University Of Minnesota Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure
US8147824B2 (en) * 1999-08-05 2012-04-03 Athersys, Inc. Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
US20030161817A1 (en) * 2001-03-28 2003-08-28 Young Henry E. Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
WO2001021767A2 (en) * 1999-09-24 2001-03-29 Morphogen Pharmaceuticals, Inc. Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
EP2333049A1 (en) * 1999-09-24 2011-06-15 ABT Holding Company Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
US6685936B2 (en) * 1999-10-12 2004-02-03 Osiris Therapeutics, Inc. Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantation
WO2001039784A1 (en) * 1999-12-06 2001-06-07 The General Hospital Corporation Pancreatic stem cells and their use in transplantation
WO2001062901A2 (en) * 2000-02-26 2001-08-30 Artecel Sciences, Inc. Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
US7582292B2 (en) * 2000-02-26 2009-09-01 Artecel, Inc. Adipose tissue derived stromal cells for the treatment of neurological disorders
JP4795616B2 (ja) 2000-06-20 2011-10-19 イーエス・セル・インターナショナル・プライヴェート・リミテッド Bmp−2経路アンタゴニストの存在下においてes細胞を培養することによって胚性幹細胞の分化をコントロールする方法
US20020061587A1 (en) * 2000-07-31 2002-05-23 Piero Anversa Methods and compositions for the repair and/or regeneration of damaged myocardium
WO2002028391A1 (en) * 2000-10-06 2002-04-11 The Regents Of The University Of California Blocking inflammation by inhibiting sialylation
US7560280B2 (en) * 2000-11-03 2009-07-14 Kourion Therapeutics Gmbh Human cord blood derived unrestricted somatic stem cells (USSC)
KR100915483B1 (ko) * 2000-12-06 2009-09-03 로버트 제이 하리리 태반 줄기 세포의 회수 방법
US7311905B2 (en) * 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
JP2004528021A (ja) * 2001-02-14 2004-09-16 アンスロジェネシス コーポレーション 分娩後の哺乳動物の胎盤、その使用およびそれに由来する胎盤幹細胞
IL157332A0 (en) * 2001-02-14 2004-02-19 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
US7056738B2 (en) * 2001-03-23 2006-06-06 Tulane University Early stage multipotential stem cells in colonies of bone marrow stromal cells
KR100449141B1 (ko) * 2001-04-19 2004-09-21 (주)라이프코드 간엽 간세포를 신경세포로 분화시키는 방법
US20030003090A1 (en) * 2001-05-31 2003-01-02 Prockop Darwin J. Directed in vitro differentiation of marrow stromal cells into neural cell progenitors
JP2005514004A (ja) 2001-08-23 2005-05-19 リライアンス ライフ サイエンシイズ ピーヴィーティー., エルティーディー ヒト胚性幹細胞(hESC)株の樹立のための内部細胞塊の単離
US9969980B2 (en) 2001-09-21 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
US6703279B2 (en) 2002-01-04 2004-03-09 Promos Technologies, Inc. Semiconductor device having contact of Si-Ge combined with cobalt silicide
US7169610B2 (en) 2002-01-25 2007-01-30 Genzyme Corporation Serum-free media for chondrocytes and methods of use thereof
US7145057B2 (en) 2002-02-01 2006-12-05 Origen Therapeutics, Inc. Chimeric bird from embryonic stem cells
US20030181269A1 (en) 2002-03-20 2003-09-25 Sara Griffin Portable, non-slip training aid for sports
US6962940B2 (en) * 2002-03-20 2005-11-08 Celgene Corporation (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
GB0221481D0 (en) 2002-09-16 2002-10-23 Richards John M Grip for hand held instruments
US20040171147A1 (en) * 2002-11-26 2004-09-02 Hariri Robert J. Cytotherapeutics, cytotherapeutic units and methods for treatments using them
US7785601B2 (en) * 2002-12-31 2010-08-31 Sygnis Bioscience Gmbh & Co. Kg Methods of treating neurological conditions with hematopoietic growth factors
WO2004069172A2 (en) * 2003-01-30 2004-08-19 The Government of the United States of America as represented by the Department of Veterans Affairs Multilineage-inducible cells and uses thereof
US20040235165A1 (en) * 2003-05-19 2004-11-25 Darwin Prockop In vitro differentiation of adult stem cells
WO2004108910A1 (en) * 2003-06-03 2004-12-16 Organ Recovery Systems, Inc. Selection and propagation of progenitor cells
EP1641915B1 (en) * 2003-06-27 2016-07-27 DePuy Synthes Products, Inc. Repair and regeneration of ocular tissue using postpartum-derived cells
WO2005041944A2 (en) * 2003-06-27 2005-05-12 Schepens Eye Research Institute Methods and compositions for promoting axon regeneration and cell replacement therapy
US20060210544A1 (en) * 2003-06-27 2006-09-21 Renomedix Institute, Inc. Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient
US7267960B2 (en) * 2003-07-25 2007-09-11 Amgen Inc. Antagonists and agonists of LDCAM and methods of use
ITRM20030376A1 (it) * 2003-07-31 2005-02-01 Univ Roma Procedimento per l'isolamento e l'espansione di cellule staminali cardiache da biopsia.
CN1845987A (zh) * 2003-08-29 2006-10-11 明尼苏达大学董事会 肾来源的干细胞及其分离、分化和使用方法
CA2538231A1 (en) * 2003-09-08 2005-03-24 Yeda Research And Development Co. Ltd. A method for treating or inhibiting the effects of injuries or diseases that result in neuronal degeneration
EP1685236A4 (en) * 2003-09-29 2008-01-23 Univ California METHODS FOR MODIFYING ADHESION, DIFFERENTIATION AND MIGRATION OF HEMATOPOIETIC PROGENITOR CELLS
US8124072B2 (en) * 2003-09-29 2012-02-28 Soft Gel Technologies, Inc. Solubilized CoQ-10
US20050089513A1 (en) * 2003-10-28 2005-04-28 Norio Sakuragawa Side population cells originated from human amnion and their uses
EP2824175B2 (en) * 2004-03-22 2020-10-28 Mesoblast International Sàrl Mesenchymal stem cells and uses therefor
US20080095749A1 (en) * 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
US7622108B2 (en) * 2004-04-23 2009-11-24 Bioe, Inc. Multi-lineage progenitor cells
BRPI0511287A (pt) * 2004-05-17 2007-12-04 Univ Minnesota uso de células-tronco do sangue do cordão umbilical para tratar evento isquêmico
PL1981515T3 (pl) * 2006-01-23 2014-02-28 Athersys Inc Leczenie urazów i chorób mózgu za pomocą MAPC
EP2392339A1 (en) * 2006-01-23 2011-12-07 Athersys, Inc. MAPC Therapeutics without adjunctive immunosuppressive treatment
WO2008057469A1 (en) * 2006-11-02 2008-05-15 Wyeth Small organic molecule regulators of cell proliferation
WO2009043159A1 (en) * 2007-10-01 2009-04-09 The Hospital For Sick Children Neural tumor stem cells and methods of use thereof
US20090130092A1 (en) * 2007-10-30 2009-05-21 Pinsky David J Nucleotide phosphate dissipation as a treatment for vascular disorders

Similar Documents

Publication Publication Date Title
JP2013500012A5 (OSRAM)
Kumar Dendritic cells in sepsis: potential immunoregulatory cells with therapeutic potential
WO2008083174A3 (en) Compositions and methods for the treatment of infections and tumors
MX2020012270A (es) Métodos para tratar cánceres y potenciar la eficacia de agentes terapéuticos para el redireccionamiento de células t.
Zhang et al. Combination of photothermal therapy with anti‐inflammation therapy attenuates the inflammation tumor microenvironment and weakens immunosuppression for enhancement antitumor treatment
JP2016530879A5 (OSRAM)
JP2010516259A5 (OSRAM)
Hazrati et al. The potential application of encapsulated exosomes: A new approach to increase exosomes therapeutic efficacy
JP2016534094A5 (OSRAM)
JP2015043779A5 (OSRAM)
JP2013530155A5 (OSRAM)
CN104127873B (zh) 一种由纳米材料和外加辐射源组成的实现肿瘤血管阻断的肿瘤治疗药物
AR061986A1 (es) Agentes inductores de muerte celular
JP2016183163A5 (OSRAM)
JP2012506394A5 (OSRAM)
PE20061203A1 (es) Combinacion de xolair con agente inmunosupresor
MX2020005878A (es) Pautas posológicas para la movilización de células madre y progenitoras hematopoyéticas.
JP2015519367A5 (OSRAM)
JP2011521967A5 (OSRAM)
IL307842A (en) Methods and compositions for treating glioblastoma
WO2022221619A8 (en) Treatment of peanut allergy with tolerizing nanoparticles
Vidal et al. Online role play: relationship psychotherapy and internal psychodrama in contemporary psychodrama
JP2019508056A5 (OSRAM)
De Maria et al. Revisited function of human NK cell subsets
Kulchitsky et al. Biomedical prospects for the use of stem cells for the treatment of gliomas